0000-0001-5890-6030 About
Prof. Waleed Hassan Almalki is a professor of pharmacology at the Umm Al-Qura University, Department of Pharmacology Makkah, Saudi Arabia. He earned his doctoral degree from the University of Glasgow, United Kingdom having a dissertation on ocular pharmacology. His current research is focused on the broad areas of host-virus network in hepacivirus C disease progression as well as host-virus genes expression during oxidative stress, hepatic steatosis, fibrosis, and hepatocellular carcinoma, toxicology as well as novel drug delivery in the effective management of various dreadful disorders. He is also enthusiastically involved in the studies of tyrosine kinase inhibitors for the treatment of breast and colon cancer, in the Saudi population. Prof. Waleed has published many research and review articles in peer-reviewed international journals on HCV pathogenesis, treatment and drug designing as well as edited various book chapters about pathological angiogenesis, pharmacological assays and infectious disease epidemiology.
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (171)
- Folate-modified chitosan nanocarriers in precision oncology: molecular engineering, targeted drug delivery, and clinical perspectives Save
- Exploring New Frontiers in Osteosarcoma Treatment: Clinical Trial Insights Save
- Corrigendum to “Multi-omics biomarker in adrenocortical carcinoma: a clinical-chemistry perspective” [Clin. Chim. Acta 590 (2026) 121103] Save
- Electrochemical biosensors for MLKL-related necroptosis biomarkers in lung cancer: From bench to clinical laboratory Save
- Integrative co-delivery platforms for paclitaxel: Advancing synergistic breast cancer therapy Save
- Nano-Based Therapeutics in Rare Disease Management: Current Perspectives, Challenges, and Unmet Needs Save
- Enhanced topical delivery of terbinafine HCl nanomicelles embedded in chitosan gel for improved antifungal activity Save
- Engineering casein nanocarriers: Innovative formulation tactics for precision cancer drug delivery: A mini review Save
- Advancing Regenerative Medicine with 3D Bioprinting: Techniques, Biomaterials, and Clinical Applications Save
- Nano-Enabled Phytotherapeutics for Obesity Management: Translating Preclinical Discoveries into Clinical Opportunities Save
- AIM2 inflammasome and pyroptosis biomarkers in oncology Save
- Key principles and guidance for the development of lncRNA targeting cancer therapeutics Save
- Immune checkpoint targeted drug conjugate therapies: Bridging preclinical and clinical innovation for solid tumor therapy Save
- Addressing Unmet Needs in Clostridium difficile Infection: Advances in Diagnosis, Treatment, and Prevention Save
- The emerging role of non-coding RNAs in the Wnt/β-catenin signaling pathway in Prostate Cancer Save
- Opuntioideae cactus stem <scp>Bioimaging</scp> analysis: Bridging taxonomy and antimicrobial research Save
- A Comprehensive review on Pharmacokinetic Studies of Vaccines: Impact of delivery route, carrier-and its modulation on immune response Save
- From nature to therapy: Luteolin's potential as an immune system modulator in inflammatory disorders Save
- Recent advances in novel miRNA mediated approaches for targeting breast cancer Save
- Superficial Dermatophytosis across the World’s Populations: Potential Benefits from Nanocarrier-Based Therapies and Rising Challenges Save